Personal tools

Sponsorname

Your company could advertise here

www.fla-consulting.eu

Property:RefUnit

From GxPlex

Jump to: navigation, search

Text

Unit number this reference belongs to.

previous 202050100250500next 20
Showing 20 pages using this property.
G
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Article 2 investigational medicinal product +
3.4.2  +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 7 Part 2 2. +
3.4.2  +
GBR The Medicines for Human Use (Clinical Trials) Regulations 2004 01-May-2004 Schedule 1 Part 2 12. +
3.4.2  +
U
USA 21 CFR Part 50 09-Apr-2025 § 50.3 (j) +
3.4.2  +
USA 21 CFR Part 812 09-Apr-2025 § 812.3 (g) +
3.4.2  +
USA 21 CFR Part 812 09-Apr-2025 § 812.3 (m) +
3.4.2  +
USA 21 CFR Part 812 09-Apr-2025 § 812.3 (r) +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.6 - §312.8 ; § 312.10 +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.40 (c) (d) +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.53 (b) +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.61 +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.62 (a) +
3.4.2  +
USA 21 CFR Part 312 09-Apr-2025 § 312.69 +
3.4.2  +
USA 21 CFR Part 812 09-Apr-2025 § 812.110 (c) +
3.4.2  +
USA 21 CFR Part 812 09-Apr-2025 § 812.140 (a) (2) +
3.4.2  +
I
ICH ICH E6 Guideline R3 (2025) GLOSSARY - Compliance (in relation to trials) +
4.1.1  +
ICH ICH E6 Guideline R3 (2025) III. Annex 1 2.5 +
4.1.1  +
ICH ICH E6 Guideline R3 (2025) Appendix B 2.5 +
4.1.1  +
W
WHO WHO - Guidelines for GCP for trials on pharmaceutical products* 1995 4.4 - Introduction +
4.1.1  +
WHO WHO - Guidance for best practices for clinical trials 2024 3.2.4 +
4.1.1  +
Retrieved from "https://gxplex.org/index.php?title=Property:RefUnit&oldid=20454"